Rapid Development of High-Quality, Robust Mammalian Cell Culture Manufacturing Processes

With increasing industry emphasis on providing both rapid and robust processes, companies are reaping the benefits of new tools for risk management and process analytical controls. As a current example of these approaches, FUJIFILM Diosynth Biotechnologies’ scientists have accelerated the development process from gene to finish by shortening the timeline, incorporating quality by design (QbD) principles, and designing the process to be as robust as possible.

View the article from BioProcess International’s Sept 2016 issue.

Figure 1: Tools for speed to clinic

Figure 1: Tools for speed to clinic